Title:
COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS
Document Type and Number:
WIPO Patent Application WO/2022/161468
Kind Code:
A1
Abstract:
The invention provides pharmaceutical compositions of berberine ursodeoxycholate (BUDCA) and methods of use thereof for the treatment primary sclerosing cholangitis, and related diseases and conditions.
Inventors:
LIU LIPING (CN)
Application Number:
PCT/CN2022/074670
Publication Date:
August 04, 2022
Filing Date:
January 28, 2022
Export Citation:
Assignee:
SHENZHEN HIGHTIDE BIOPHARMACEUTICAL LTD (CN)
International Classes:
A61K31/4375; A61K9/20; A61K9/48; A61K31/4745; A61P1/16; C07D455/03; C07J9/00
Domestic Patent References:
| WO2016015634A1 | 2016-02-04 |
Foreign References:
| US20200188387A1 | 2020-06-18 | |||
| US20170143742A1 | 2017-05-25 |
Other References:
DING JIAXIN, YANG TINGTING, JIANG ZHENZHOU, ZHANG LUYONG: "Research Progress in Potential Therapeutic Drugs for Cholestatic Liver Diseases", PROGRESS IN PHARMACEUTICAL SCIENCES, vol. 42, no. 10, 25 October 2018 (2018-10-25), pages 772 - 779, XP055955777
SHORBAGI ALI, BAYRAKTAR YUSUF: "Primary sclerosing cholangitis - What is the difference between east and west?", WORLD JOURNAL OF GASTROENTEROLOGY, WJG PRESS, CN, vol. 14, no. 25, 7 July 2008 (2008-07-07), CN , pages 3974, XP055955780, ISSN: 1007-9327, DOI: 10.3748/wjg.14.3974
SHORBAGI ALI, BAYRAKTAR YUSUF: "Primary sclerosing cholangitis - What is the difference between east and west?", WORLD JOURNAL OF GASTROENTEROLOGY, WJG PRESS, CN, vol. 14, no. 25, 7 July 2008 (2008-07-07), CN , pages 3974, XP055955780, ISSN: 1007-9327, DOI: 10.3748/wjg.14.3974
Attorney, Agent or Firm:
SHENZHEN ZHONGDING INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: